MedTrace Logo

Garcinia Mangostana L Rind and Solanum Lycopersicum Fructus Trial to Prevent Exercise-induced Oxidative Stress

NCT03899454 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-07-30

No results posted yet for this study

Summary

Treatments are an administration of a mixed extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351) and placebo control.

Conditions

  • Exertion; Excess
  • Oxidative Stress

Interventions

DRUG

Garcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extract

Administration of mixed extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351)

DRUG

Placebo Control

Placebo Control

Sponsors & Collaborators

  • Ministry of Research, Technology and Higher Education, Republic of Indonesia

    collaborator UNKNOWN

  • Universitas Negeri Semarang

    lead OTHER

Principal Investigators

  • Mahalul Azam · Universitas Negeri Semarang

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2020-09-15
Completion
2022-09-15

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03899454 on ClinicalTrials.gov